Fine Particulate Matter Constituents, Ozone, and Systemic Lupus Erythematosus: A Large General-Population Cohort Analysis With Extended Quantile g-Computation - Takeaways - MDSpire

Components of Fine Particulate Matter, Ozone Levels, and Their Association with Systemic Lupus Erythematosus: Analysis from a Large General-Population Cohort Using Extended Quantile g-Computation

  • By

  • Naizhuo Zhao

  • Sasha Bernatsky

  • Sharon Dowell

  • Brittany Banbury

  • Jeffrey R. Curtis

  • Grace C. Wright

  • Emily E. Holladay

  • Amy Mudano

  • Cristiano S. Moura

  • Gail S. Kerr

  • June 9, 2026

Share

  • 1

    Systemic lupus erythematosus (SLE) affects approximately 3.4 million people globally, with air pollution, particularly PM2.5, suggested as a potential risk factor.

  • 2

    PM2.5 consists of various chemical constituents from different sources, which may have distinct health effects related to SLE.

  • 3

    Ozone frequently co-occurs with PM2.5 and may modify the toxicity of PM2.5 constituents, influencing the risk of autoimmune diseases.

  • 4

    Quantile g-computation is an effective method for assessing the health impacts of multiple environmental exposures, avoiding issues of collinearity.

  • 5

    The study utilized a large US administrative cohort to investigate the association between PM2.5 constituents, ozone, and incident SLE.

Original Source(s)

Fine Particulate Matter Constituents, Ozone, and Systemic Lupus Erythematosus: A Large General-Population Cohort Analysis With Extended Quantile g-Computation

  • by Naizhuo Zhao, Sasha Bernatsky, Sharon Dowell, Brittany Banbury, Jeffrey R. Curtis, Grace C. Wright, Emily E. Holladay, Amy Mudano, Cristiano S. Moura, Gail S. Kerr

  • June 9, 2026

Related Content

A Qualitative Analysis of Patient Perspectives and Preferences in Lupus Management to Guide Lupus Guidelines Development

Does TYK2/JAK1 Show Potential in Inflammatory Diseases?

Investigational inhibitor was not associated with treatment-related serious adverse events and produced biomarker changes consistent with pathway inhibition in healthy volunteers.

Gene expression profiling of dendritic cell tolerance dysfunction in women with systemic lupus erythematosus